Updated 16 October 2024
Date of the remote assessment was Friday 22 November 2024 and on-site inspection activity took place on Tuesday 26 November 2024. The assessment was to follow up on findings of our earlier inspection conducted on 10 November 2022 where we found improvements were required in the management and monitoring of medicines. The practice was fully supportive of the assessment, which examined those risks. No breaches of regulations were identified.